牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 3,002 shares of common stock on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sanna, who has sold a total of 7,147 shares in the past three months, amounting to gross proceeds of $3,000,307.10. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 08/25/2023.
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 3,002 shares of common stock on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sanna, who has sold a total of 7,147 shares in the past three months, amounting to gross proceeds of $3,000,307.10. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 08/25/2023.
Vertex Pharmicals Inc.高管巴斯蒂亞諾·桑納定於2024年2月21日出售3,002股普通股，總市值爲1,266,153.54美元。這些股票於2024年2月20日作爲績效股票收購，這是發行人的一種補償形式。該交易遵循了Sanna最近的銷售歷史，該公司在過去三個月中共出售了7,147股股票，總收益爲3,000,307.10美元。計劃出售的通知是在出售的同一天提交的，該交易的計劃已於2023年8月25日通過。
Vertex Pharmicals Inc.高管巴斯蒂亞諾·桑納定於2024年2月21日出售3,002股普通股，總市值爲1,266,153.54美元。這些股票於2024年2月20日作爲績效股票收購，這是發行人的一種補償形式。該交易遵循了Sanna最近的銷售歷史，該公司在過去三個月中共出售了7,147股股票，總收益爲3,000,307.10美元。計劃出售的通知是在出售的同一天提交的，該交易的計劃已於2023年8月25日通過。
有用
沒用
該公告為獨立文件：